Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Carlsson, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Carlsson, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Drug-induced torsade de pointes: the perspectives of industry

L. Carlsson*

Integrative Pharmacology, AstraZeneca Research & Development Mölndal, Sweden

* Correspondence: Leif Carlsson, PhD, AstraZeneca Research & Development Mölndal, Integrative Pharmacology, S-431 83 Mölndal, Sweden.

Abstract

The appearance of QT prolongation and torsades de pointes during drug treatment is often unpredictable and has been recognised as a potential risk during treatment with antiarrhythmic as well as non-antiarrhythmic drugs. As a consequence, both regulatory bodies and the pharmaceutical industry are presently addressing the importance of early preclinical testing of novel compounds to identify QT prolongation and reassure safe clinical usage of new chemical entities. This paper briefly discusses some of the suggested in vitro methodologies and the predictive value of preclinical in vivo studies for assessment of repolarization delay of novel chemical entities.

Key Words: Drugs • action potential • repolarization • QT interval • torsade de pointes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.